2.55 Hydroxychloroquine for COVID-19, ASCO, QOTW, Private Equity in Medicine with Dr. Jane Zhu

Plenary Session

English - June 05, 2020 02:28 - 2 hours - 122 MB - ★★★★★ - 732 ratings
Science Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 2.54 Classical Hematology Chat on Thrombosis in COVID-19 & Drugs for COVID-19 with Dr. Walid Gellad

Next Episode: 2.56 HER2CLIMB & Misinformation and Disinformation with Dr. Cailin O'Connor

We start this week's episode by covering some recent research: After thoroughly critiquing the recent randomized trial of hydroxychloroquine for postexposure prophylaxis for COVID-19, we then discuss the five abstracts selected for plenary sessions at the recent virtual meeting of the American Society of Clinical Oncology. We transition from there to a Question from a Medical Student with Audrey Tran of Oregon Health & Science University on the recent decision to make the USMLE Step 1 exam pass/fail. Finally, we end with an interview with Dr. Jane Zhu, also of OHSU, on her current research and her new paper published in JAMA titled, "Private Equity Acquisitions of Physician Medical Groups Across Specialties, 2013-2016". Dr. Zhu first guest-starred on Plenary Session in episode 1.31.

Hydroxychloroquine: doi.org/10.1056/NEJMoa2016638
JAVELIN: https://meetinglibrary.asco.org/record/186872/abstract
ECOG-ACRIN: https://meetinglibrary.asco.org/record/186884/abstract
ENDURANCE: https://meetinglibrary.asco.org/record/186906/abstract
KEYNOTE-177: https://meetinglibrary.asco.org/record/186928/abstract
ADAURA: https://meetinglibrary.asco.org/record/191929/abstract
Private Equity Acquisitions: doi.org/10.1001/jama.2019.21844

Listen to the audiobook of Malignant with a free 30-day trial from Audible! https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us

Back us on Patreon! www.patreon.com/plenarysession